Torrent Pharma (UK) Limited (TP-UK) is a wholly owned subsidiary of Torrent Pharmaceuticals Limited, a global pharmaceutical company specialising in the manufacture and distribution of generic pharmaceutical medicines. ETHealthworld.com brings latest torrent pharmaceuticals news, views and updates from all top sources for the Indian Health industry.

Number of employees 8600 (2014) Website Torrent Pharmaceuticals Ltd. Is the flagship company of the. Amplitube 3 keygen torrent.

Based in the Indian city of. It was promoted by, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally.

Torrent Pharma is active in the therapeutic areas of Cardiovascular (CV), central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments. Contents • • • • Subsidiaries [ ] It has 7 fully owned subsidiaries: • Heumann Pharma GmbH & Co Generica KG, • Torrent Pharma GmbH, • Torrent do Brasil Ltda., • ZAO Torrent Pharma, • Torrent Pharma Inc., • Torrent Pharma Philippines Inc., • Torrent Pharma Canada Inc., • Torrent Pharma UK United Kingdom Torrent Pharmaceuticals acquired Heumann GmbH, a company, in 2005. Advantages and disadvantages of serial and parallel data transmission problems. Operations [ ] The company's key areas are Formulations, API, Drug Discovery, Marketing and Sales of Drugs. Its operations locations are: • Manufacturing plant at Dahej, • Manufacturing plant at Pithampur, • Manufacturing plant at Indrad, Mehsana, • Manufacturing plant at Baddi, • 3 Manufacturing plant at Rang-Po,(Sikkim) • Research Centre, - region, • Corporate Office, beside sales India, off.

Ashram Road, [Ahmedabad]- • Manufacturing plant at Visakhapatnam (Andhra Pradesh) Recalls [ ] In 2018, Torrent Pharmaceuticals recalled tablets containing and due to the detection of (NDMA) and (NDEA) respectively which are probable human carcinogens. References [ ]. Torrent Pharmaceuticals Limited is voluntarily recalling ALL LOTS within expiry of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. The impurity detected in the API is N-nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.

Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in the API is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.